Thomas Byrne

Thomas Byrne is an experienced pharmaceutical R&D executive with special expertise in related intellectual property law. His experience includes in-house counsel positions within both Genentech and Amgen. While at Amgen, he co-invented the erythropoiesis-stimulating agent Aranesp®. From 1992-2000 he was a partner in the intellectual property law firm of Nixon and Vanderhye P.C. Since 2000, Mr. Byrne has provided expert legal counsel for numerous start-up biotechnology and pharmaceutical companies on intellectual property, contract and business issues.

Mr. Byrne holds BS degrees in Chemical Engineering and Nuclear Engineering from the University of Virginia, an MS degree in Biochemical Engineering from Yale University, and a JD degree from the University of Virginia.